default author photo

cong Tian

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

23

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Anlotinib/Apatinib Plus Chemotherapy as Second-Line or Later Therapy in Advanced Osteosarcoma

Number of pages: 15 Posted: 08 Jul 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 23 (1,411,822)

Abstract:

Loading...

osteosarcoma, recurrent or metastatic, chemotherapy, second-line or later therapy, anlotinib/apatinib